Cite
Different Isoforms of PML-RARA Chimeric Protein in Patients with Acute Promyelocytic Leukemia: Survival Analysis per Demographic Characteristics, Clinicohematological Parameters, and Cytogenetic Findings.
MLA
Siahbani, Sarah, et al. “Different Isoforms of PML-RARA Chimeric Protein in Patients with Acute Promyelocytic Leukemia: Survival Analysis per Demographic Characteristics, Clinicohematological Parameters, and Cytogenetic Findings.” Iranian Journal of Pathology, vol. 18, no. 4, Fall 2023, pp. 456–75. EBSCOhost, https://doi.org/10.30699/ijp.2023.2007229.3145.
APA
Siahbani, S., Safaei, A., Faghih, M., Hosseini, M., Fendereski, A., Valibeigi, B., & Monabati, A. (2023). Different Isoforms of PML-RARA Chimeric Protein in Patients with Acute Promyelocytic Leukemia: Survival Analysis per Demographic Characteristics, Clinicohematological Parameters, and Cytogenetic Findings. Iranian Journal of Pathology, 18(4), 456–475. https://doi.org/10.30699/ijp.2023.2007229.3145
Chicago
Siahbani, Sarah, Akbar Safaei, Masoumeh Faghih, Marzieh Hosseini, Afsaneh Fendereski, Behnaz Valibeigi, and Ahmad Monabati. 2023. “Different Isoforms of PML-RARA Chimeric Protein in Patients with Acute Promyelocytic Leukemia: Survival Analysis per Demographic Characteristics, Clinicohematological Parameters, and Cytogenetic Findings.” Iranian Journal of Pathology 18 (4): 456–75. doi:10.30699/ijp.2023.2007229.3145.